Gastrointestinal manifestations, risk factors, and management in patients with post-transplant lymphoproliferative disorder: A systematic review

doi:10.5500/wjt.v12.i8.268

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5634)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

209

WORD

HTML

2789

Figures (1-7)

329

Tables (1-2)

371

Sum=3760

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

268

Download

641

Sum=909

Publishing Process of This Article

Item

Count

Browse

316

Download

649

Sum=965

Aug 18, 2022 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Transplant. Aug 18, 2022; 12(8): 268-280
Published online Aug 18, 2022. doi: 10.5500/wjt.v12.i8.268

Full Size Figure Download Figure

Figure 7 Workflow of the treatment for post-transplant lymphoproliferative disorder. PTLD: Post-transplant lymphoproliferative disorder; EBV: Epstein-Barr virus; GI: Gastrointestinal; MMF: Mycophenolate mofetil; ABVD: Doxorubicin, bleomycin, vinblastine, and dacarbazine; DLBCL: Diffuse large B-cell lymphomas.

Citation: Reiche W, Tauseef A, Sabri A, Mirza M, Cantu D, Silberstein P, Chandan S. Gastrointestinal manifestations, risk factors, and management in patients with post-transplant lymphoproliferative disorder: A systematic review. World J Transplant 2022; 12(8): 268-280
URL: https://www.wjgnet.com/2220-3230/full/v12/i8/268.htm
DOI: https://dx.doi.org/10.5500/wjt.v12.i8.268